Zydus Cadila’s Virafin priced at Rs 11,995 per dose


As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for C-19 treatment, at Rs 11,995 per dose. Reportedly, the company has commenced dispatching the drug which can reportedly reduce oxygen support in C-19 patients.

The Drug Controller General of India (DCGI) gave emergency authorisation for restricted use to Virafin, a single-use therapy, on April 23.

Technically known as Pegylated Interferon alpha-2b, it is used to treat moderate infection of C-19. The company has said, “91.15 per cent of patients treated with PegIFN were RT-PCR negative by day 7.”

Also read:

Govt to amend notification to allow import of oxytocin API to…

Medicine labels in Hindi along with English: DTAB dismisses proposal

Bharat Biotech begins direct supply of COVAXIN to 14 states

Vivimed Labs gets DGHS nod to Mfr Favipiravir tablets in India

Platform for Nurses, Healthcare Staff, Lab Technicians

Pharma companies are now essential services

YouTube Icon

Enter your email address:

Delivered by FeedBurner